How much does the Indian generic version of Alpelisib cost?
Alpelisib (Alpelisib) is a PI3K inhibitor targeted drug, mainly used to treat PIK3CA mutated HR positive, HER2 negative advanced breast cancer patients. Although it has been widely used in Europe and the United States and other countries, and has been approved by the FDA for use in specific groups, up to now, Apelvis has not been officially launched in mainland China, which has brought certain access barriers to patients in need of the drug.
Currently, if domestic patients want to use Apelvis, they usually need to obtain it through overseas purchasing or medical treatment overseas. It is understood that India does not produce a generic version of Apelvis, so there is no so-called "Indian generic" option. However, the original research version of Apelvis is available in the Indian market, and the price is about 3,000 RMB per box. Although the price is not low, compared with the cost of original research drugs in the European and American markets, which can easily reach tens of thousands of yuan, the Indian channel still has a certain price advantage.

It is worth noting that in addition to India, some Asian countries such as Laos have begun to have generic versions of Apelvis on the market. According to current public information, the price of the Laos imitation version of Apelvis is about 1,000 yuan, which is cheaper than the original version in India. For some patients with limited financial conditions, this is a cost-effective alternative. Of course, since the level of supervision of generic drugs varies, it is recommended that patients choose a version that has legal drug registration information and is recommended by professional channels.
To sum up, although India does not produce generic drugs of Apelvis, the price of its original drug still has an advantage compared to Europe and the United States, while the generic version in Laos provides a lower-priced option. Before a drug is launched domestically, if patients need medication, it is recommended to consult a professional doctor or a trustworthy overseas drug purchasing platform to ensure the quality, safety and therapeutic effect of the drug.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)